Anesthetics and Analgesics in Children
Pharmacokinetics of Anesthetics and Analgesics in Children and Adolescent
Chi Dang Hornik
460 participants
Dec 13, 2018
OBSERVATIONAL
Conditions
Summary
The purpose of this study is to characterize the pharmacokinetic (PK) and safety profile of anesthetics and analgesics in children and adolescents.
Eligibility
Inclusion Criteria4
- 0 to <18 years of age at time of enrollment (must see applicable appendix for details as not all appendices enroll across the entire age range)
- Parent and/or participant (if applicable) is able to understand the consent process and provides informed consent and HIPAA Authorization (if applicable)
- Participant provides assent as required by the institutional review board (IRB) or research ethics board (REB)
- Receiving one or more drugs of interest (DOI) per local standard of care
Exclusion Criteria3
- Known pregnancy
- Extracorporeal life support (i.e., ECMO, dialysis, ventricular assist device)
- Any condition which would make the participant, in the opinion of the investigator, unsuitable for the study
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
IV ketorolac will be given per standard of care, not prescribed for this study
IV Hydromorphone will be given per standard of care, not prescribed for this study
IV Ketamine will be given per standard of care, not prescribed for this study
PO Oxycodone(solution or tablet) will be given per standard of care, not prescribed for this study
IV Morphine will be given per standard of care, not prescribed for this study
Locations(13)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03427736